Literature DB >> 18160263

The incidence of infectious diseases after renal transplantation: a single-centre experience.

L Lyerová1, O Viklický, D Nemcová, V Teplan.   

Abstract

This single-centre study was designed to investigate the incidence of infections and their causative pathogens during the first three months after renal transplantation (RTx) in patients who had undergone the procedure in 2005 (n=174). We compared this group of patients with a previous one (1998-2000, n=437). In 2005, infection was diagnosed in 82 patients (47%). Symptomatic lower urinary tract infection (UTI) was present in 43 patients (25%), pyelonephritis in 15 (8.6%), and urosepsis in 7 (4%). Wound infection developed in 21 patients (12%), cytomegalovirus (CMV) disease in 15 (8.6%), and pneumonia in 5 (3%). The most frequent pathogens in UTI were Klebsiella pneumoniae and Enterococcus faecalis. Pathogens of wound infection included Staphylococcus coagulase negative and K. pneumoniae. Pneumonia was frequently caused by Mycoplasma pneumophila. Compared with the previous group, we noted decreases in the total number of infections (77.7 vs. 47%, P<0.001), pneumonia (8.5 vs. 3%, P<0.02) and UTI (33.3 vs. 24.7%, P<0.05). We observed an increased incidence of multiresistant Klebsiella. Based on these results, we have changed our scheme of antibiotic prophylaxis and the algorithms of antibiotic treatment. We reduced the use of antibiotics with an adverse epidemiological effect (quinolones, third-generation cephalosporins) and increased the use of relatively safe antibiotics (penicillins, aminopenicillins, with and without beta-lactam inhibitors).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160263     DOI: 10.1016/j.ijantimicag.2007.09.016

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus.

Authors:  Michał Zimecki; Jolanta Artym; Maja Kocieba; Beata Weber-Dabrowska; Jan Borysowski; Andrzej Górski
Journal:  Med Microbiol Immunol       Date:  2009-12-02       Impact factor: 3.402

Review 2.  Management of children after renal transplantation: highlights for general pediatricians.

Authors:  Keith K Lau; Lucy Giglia; Howard Chan; Anthony K Chan
Journal:  Transl Pediatr       Date:  2012-07

3.  Stented ureterovesical anastomosis in renal transplantation: does it influence the rate of urinary tract infections?

Authors:  Zoltan Mathe; J W Treckmann; M Heuer; A Zeiger; S Sauerland; O Witzke; A Paul
Journal:  Eur J Med Res       Date:  2010       Impact factor: 2.175

4.  Increased resistance of gram-negative urinary pathogens after kidney transplantation.

Authors:  Johannes Korth; Julia Kukalla; Peter-Michael Rath; Sebastian Dolff; Marco Krull; Hana Guberina; Anja Bienholz; Benjamin Wilde; Stefan Becker; Birgit Ross; Olympia Evdoxia Anastasiou; Andreas Kribben; Oliver Witzke
Journal:  BMC Nephrol       Date:  2017-05-19       Impact factor: 2.388

Review 5.  Prevalence and Antimicrobial Resistance of Bacterial Uropathogens Isolated from Iranian Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.

Authors:  Abbas Shapouri Moghaddam; Maryam Arfaatabar; Jalil Tavakol Afshari; Ali Shakerimoghaddam; Zahra Mohammadzamani; Azad Khaledi
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

6.  Urogenital mycoplasmas and human papilloma virus in hemodialysed women.

Authors:  Alicja Ekiel; Bronisława Pietrzak; Barbara Wiechuła; Małgorzata Aptekorz; Natalia Mazanowska; Dominika Rady; Paweł Kamiński; Gayane Martirosian
Journal:  ScientificWorldJournal       Date:  2013-12-02

7.  Comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients.

Authors:  Farzin Khorvash; Mojgan Mortazavi; Atousa Hakamifard; Behrooz Ataei
Journal:  Adv Biomed Res       Date:  2016-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.